RecruitingNCT06221488

Testing Health Workers At Risk to Advance Our Understanding of TB Infection

THWART-TB: Testing Health Workers At Risk to Advance Our Understanding of TB Infection


Sponsor

Beth Israel Deaconess Medical Center

Enrollment

300 participants

Start Date

Jan 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

It has been estimated that 1.7 billion people have tuberculosis (TB) infection; yet current tests are unable to predict which people are at highest risk of developing TB disease, which can be life-threatening. THWART-TB is a prospective longitudinal cohort study of health workers (HWs) in Cape Town, South Africa, where our preliminary data reveals HWs have a high annual TB infection risk (34%). This cohort, who will undergo frequent serial evaluation (every 3 months) with a combination of novel assays never previously evaluated together, presents a unique opportunity to evaluate immune responses at the time of initial infection and to characterize the dynamic profile of these immune responses over time in a high-risk population. The knowledge generated will improve our understanding of TB infection and help to identify which people exposed to TB may remain at risk, enabling us to better target preventive strategies.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

  • ≥18 years old
  • Health worker
  • Able to provide informed consent

Exclusion Criteria2

  • Prior history of TB or known prior positive IGRA
  • Current or prior history of taking anti-TB treatment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTTB infection testing

Diagnostic testing with existing and novel tests to evaluate for TB infection and disease


Locations(1)

Stellenbosch University

Cape Town, South Africa

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06221488


Related Trials